Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,648.00
(
0.39%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
95.97
(
5.05%
)
Bitcoin
70,909.98
(
-3.60%
)
News Focus
News Focus
Post# of 828605
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dennisdave

Send PM Follow Ignore
Followers 42
Posts 5340
Boards Moderated 0
Alias Born 12/05/2021

dennisdave

Re: exwannabe post# 702613

Sunday, 06/30/2024 3:17:29 PM

Sunday, June 30, 2024 3:17:29 PM

Post# of 828605
You conveniently forget that after UK approval every GBM patient on the globe with money will flock to NWBO to get DCVAXL.
Every year globally, more than 300,000 cases of glioblastoma are diagnosed x 20% with the means to pay for the treatment = 60k ok 30k ok 10k ok 5k patients that will ring NWBO in 2025 x 200k = 1 billion revenue ok 500 million revenue ok 250 million ok $150 million in revenue ... in 2025

the point is NICE will not determine NWBO's revenue in 2025 the 300k patients worldwide will.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News